A novel and potent FLT3 and IRAK4 dual inhibitor for the treatment of acute myeloid leukemia

被引：1
|
作者：
Yang, Rui
Wu, Lei
Zhang, Bing
Xiang, Michael
Wang, Suyue
Xiang, Camille
Lu, Zhijian
Xiang, Jason
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4492
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4492
引用
收藏
页数：2
相关论文
共 50 条
  • [21] MZH29 is a novel potent inhibitor that overcomes drug resistance FLT3 mutations in acute myeloid leukemia
    Xu, B.
    Zhao, Y.
    Wang, X.
    Gong, P.
    Ge, W.
    LEUKEMIA, 2017, 31 (04) : 913 - 921
  • [22] MZH29 is a novel potent inhibitor that overcomes drug resistance FLT3 mutations in acute myeloid leukemia
    B Xu
    Y Zhao
    X Wang
    P Gong
    W Ge
    Leukemia, 2017, 31 : 913 - 921
  • [23] Characterization of a Novel FLT3 BITE Molecule for the Treatment of Acute Myeloid Leukemia
    Brauchle, Bettina
    Goldstein, Rebecca L.
    Karbowski, Christine M.
    Henn, Anja
    Li, Chi-Ming
    Buecklein, Veit L.
    Krupka, Christina
    Boyle, Michael C.
    Koppikar, Priya
    Haubner, Sascha
    Wahl, Joachim
    Dahlhoff, Christoph
    Raum, Tobias
    Rardin, Matthew J.
    Sastri, Christine
    Rock, Dan A.
    Von Bergwelt-Baildon, Michael
    Frank, Brendon
    Metzeler, Klaus H.
    Case, Ryan
    Friedrich, Matthias
    Balazs, Mercedesz
    Spiekermann, Karsten
    Coxon, Angela
    Subklewe, Marion
    Arvedson, Tara
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (09) : 1875 - 1888
  • [24] Novel dual resistance mechanism of acute myeloid leukemia cells to FLT3 inhibitors
    Katayama, Kazuhiro
    CANCER SCIENCE, 2024, 115 : 675 - 675
  • [25] Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia
    Wang, Eunice S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) : 154 - 162
  • [26] MRX2843, A NOVEL DUAL MERTK & FLT3 INHIBITOR WITH ACTIVITY AGAINST RESISTANCE-CONFERRING FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA
    Minson, Katherine
    Smith, Catherine
    Lee-Sherick, Alisa
    Libbrecht, Clara
    DeRyckere, Deborah
    Lasater, Elisabeth
    Hill, Amanda
    Wang, Xiaodong
    Frye, Stephen
    Earp, H. Shelton, III
    Shah, Neil
    Graham, Douglas
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 27 - 27
  • [27] LT-171-861, a novel FLT3 inhibitor, shows excellent preclinical efficacy for the treatment of FLT3 mutant acute myeloid leukemia
    Yu, Zhou
    Du, Jiaying
    Hui, Hui
    Kan, Shaoxin
    Huo, Tongxin
    Zhao, Kai
    Wu, Tao
    Guo, Qinglong
    Lu, Na
    THERANOSTICS, 2021, 11 (01): : 93 - 106
  • [28] Treatment of Acute Myeloid Leukemia with the FLT3 Gene Mutation
    Carlos Best-Aguilera
    O. Rodrigo Gómez-Vázquez
    A. Elizabeth Guzmán-Hernández
    R. Monserrat Rojas-Sotelo
    Current Oncology Reports, 2017, 19
  • [29] Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia
    Levis, Mark
    FUTURE ONCOLOGY, 2014, 10 (09) : 1571 - 1579
  • [30] Treatment of Acute Myeloid Leukemia with the FLT3 Gene Mutation
    Best-Aguilera, Carlos
    Gomez-Vazquez, O. Rodrigo
    Guzman-Hernandez, A. Elizabeth
    Rojas-Sotelo, R. Monserrat
    CURRENT ONCOLOGY REPORTS, 2017, 19 (03)
12345